| scholarly article | Q13442814 |
| review article | Q7318358 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1097/QCO.0B013E328336A23F |
| P698 | PubMed publication ID | 20075728 |
| P2093 | author name string | Carlos M Luna | |
| Iris D Boyeras Navarro | |||
| P2860 | cites work | Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 |
| Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults | Q22242958 | ||
| Vaccine protection against Staphylococcus aureus pneumonia | Q24650703 | ||
| Genome and virulence determinants of high virulence community-acquired MRSA | Q28202214 | ||
| Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia | Q28286874 | ||
| Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms | Q28374448 | ||
| Invasive methicillin-resistant Staphylococcus aureus infections in the United States | Q29616087 | ||
| Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season | Q30228895 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors | Q30310410 | ||
| Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve | Q33181940 | ||
| Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study | Q34268116 | ||
| Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin | Q34544309 | ||
| Tigecycline pharmacokinetic/pharmacodynamic update | Q34595238 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin | Q34788301 | ||
| Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia | Q34999661 | ||
| Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis | Q35030135 | ||
| Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. | Q35091151 | ||
| Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991 | Q35614812 | ||
| Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat | Q36108084 | ||
| Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? | Q36412379 | ||
| Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia | Q36428418 | ||
| Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. | Q36735202 | ||
| Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia | Q36856249 | ||
| Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature | Q36930855 | ||
| Empyema necessitatis due to methicillin-resistant Staphylococcus aureus: case report and review of the literature | Q36933433 | ||
| Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease | Q36953300 | ||
| Antimicrobial therapy of Staphylococcus aureus bloodstream infection | Q36968150 | ||
| Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review | Q37098355 | ||
| Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. | Q37150599 | ||
| Pneumonia caused by methicillin-resistant Staphylococcus aureus | Q37156705 | ||
| Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America | Q37558855 | ||
| Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus | Q38387768 | ||
| Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus | Q39477045 | ||
| Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains | Q39651444 | ||
| Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices | Q39771366 | ||
| Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin | Q44479148 | ||
| Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia | Q44647040 | ||
| Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. | Q44727670 | ||
| Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy | Q44959085 | ||
| Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections | Q44987609 | ||
| Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. | Q45981296 | ||
| Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets. | Q46164703 | ||
| A worldwide perspective of atypical pathogens in community-acquired pneumonia. | Q46353484 | ||
| Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia | Q46589068 | ||
| Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin? | Q46728126 | ||
| Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. | Q46878727 | ||
| Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. | Q51643088 | ||
| Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 | ||
| Ventilator-Associated Pneumonia | Q57237894 | ||
| Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes | Q57238158 | ||
| Ubiquitous Presence of a mecA Homologue in Natural Isolates of Staphylococcus sciuri | Q57712561 | ||
| Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus | Q72300805 | ||
| The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia | Q74304398 | ||
| Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia | Q79436924 | ||
| [Clinical guidelines for the treatment of nosocomial pneumonia in Latin America: an interdisciplinary consensus document. Recommendations of the Latin American Thoracic Society] | Q81103956 | ||
| Emergence of staphylococcal cassette chromosome mec type IV methicillin-resistant Staphylococcus aureus as a cause of ventilator-associated pneumonia | Q81167420 | ||
| P433 | issue | 2 | |
| P921 | main subject | pneumonia | Q12192 |
| Staphylococcus aureus | Q188121 | ||
| methicillin-resistant Staphylococcus aureus | Q595158 | ||
| P304 | page(s) | 178-184 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Management of methicillin-resistant Staphylococcus aureus pneumonia | |
| P478 | volume | 23 |
| Q36684542 | Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4 |
| Q37868426 | Controlling the Evolution of Resistance |
| Q33790761 | Differences in hospital- and ventilator-associated pneumonia due to Staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between Europe and Latin America: a comparison of the EUVAP and LATINVAP study cohorts |
| Q50517899 | ROS-mediated killing efficiency with visible light of bacteria carrying different red fluorochrome proteins. |
| Q47771466 | Retracted publications in the drug literature |
| Q84510195 | Retraction: management of methicillin-resistant Staphylococcus aureus pneumonia |
| Q36913042 | Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections |
| Q43703140 | Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study |
Search more.